VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 362 filers reported holding VANECK VECTORS ETF TR in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,678,000 | -28.2% | 61,278 | +0.6% | 0.27% | -15.3% |
| Q1 2022 | $2,336,000 | -1.8% | 60,903 | -18.0% | 0.31% | +4.3% |
| Q4 2021 | $2,378,000 | +8.4% | 74,239 | -0.3% | 0.30% | +2.0% |
| Q3 2021 | $2,194,000 | -13.5% | 74,457 | -0.3% | 0.30% | -13.0% |
| Q2 2021 | $2,537,000 | +3.3% | 74,673 | -1.2% | 0.34% | -2.3% |
| Q1 2021 | $2,456,000 | -49.6% | 75,566 | -44.1% | 0.35% | -53.7% |
| Q4 2020 | $4,872,000 | -6.4% | 135,258 | +1.8% | 0.75% | -20.8% |
| Q3 2020 | $5,204,000 | +7.7% | 132,890 | +0.8% | 0.95% | -1.9% |
| Q2 2020 | $4,833,000 | +114.3% | 131,771 | +34.6% | 0.96% | +78.8% |
| Q1 2020 | $2,255,000 | -23.2% | 97,891 | -2.4% | 0.54% | -4.9% |
| Q4 2019 | $2,935,000 | +8.8% | 100,252 | -0.7% | 0.57% | -0.5% |
| Q3 2019 | $2,697,000 | +917.7% | 100,987 | +907.1% | 0.57% | +738.2% |
| Q3 2016 | $265,000 | – | 10,028 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |